ClinicalTrialsFinder

Human Immunodeficiency Virus Type 1 (HIV-1) Infection Clinical Trials in Washington D.C., District of Columbia

1 recruitingWashington D.C., District of Columbia

Showing 1–1 of 1 trials

Recruiting
Phase 2Phase 3

A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)

Human Immunodeficiency Virus Type 1 (HIV-1) Infection
Merck Sharp & Dohme LLC570 enrolled47 locationsNCT07266831